Delivery Order SPE2DB22D2007-SPE2DB24FJ3DH

Award Date 6/5/24
Potential Completion Date 6/6/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,359.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ATROPINE 0.4 MG/ML VIALML, a critical medical product, with a completion date of June 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Atropine 8 mg/20 ml vials, a critical medical product, with a ceiling value of $1,044.04. The contract has an ultimate completion date of August 12, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen leverages its extensive supply chain network to provide a wide range of...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order valued at $1,078.53 and is for the delivery of ATROPINE 8 MG/20 ML VIAL 20ML medical supplies. The contract has a firm fixed price pricing type and a final completion date of February 26, 2025. This contract award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atropine 1 mg/ml vials, a critical medical commodity, with a ceiling value of $1,043.17 and a completion date of February 24, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award, valued at $23,152.79, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order to provide 4,558,096,028 units of Atropine 1ML Vial 25S, a critical medical supply. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain to fulfill government contracts, particularly with the Department of Defense (DoD) and Veterans...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,378.10 firm fixed-price delivery order is for the supply of 4567364187 - ATROPINE 8 MG/20 ML VIAL 20ML. The contract has a period of performance through February 25, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $3,459.76, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award, valued at $10,548.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Atropine 1 mg/ml vials, a critical pharmaceutical product, with a completion date of December 1, 2023. The contract is a Firm Fixed Price Delivery Order, and there was no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Atropine 1 mg/ml vial. The contract has a ceiling value of $8,252.57 and is a Firm Fixed Price Delivery Order with a completion date of September 26, 2023. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for...
The federal government has awarded a delivery order contract worth $4,111.22 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564389772 - ATROPINE 8 MG/20 ML VIAL 20ML. This contract has an ultimate completion date of April 25, 2024 and was awarded on April 24, 2024 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, holds a...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ3DH
    Delivery Order

This federal contract award, valued at $1,429.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of ATROPINE 8 MG/20 ML VIAL 20ML, a pharmaceutical product, with a completion date of June 6, 2024.

Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.

The contract award does not have a set-aside designation, indicating it was competed on a full and open basis. Amerisourcebergen's expertise in pharmaceutical distribution and its ability to leverage the extensive supply chain network of its parent company, Amerisourcebergen Corporation, have contributed to the company's competitive position in the federal pharmaceutical supply market.

Generated 9/4/24, 9:16 AM